Zur Rose Group Stock Forecast, Price & News

0.00 (0.00 %)
(As of 06/22/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Average Volume1,847 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ZRSEF News and Ratings via Email

Sign-up to receive the latest news and ratings for Zur Rose Group and its competitors with MarketBeat's FREE daily newsletter.

Zur Rose Group logo

About Zur Rose Group

Zur Rose Group AG operates an e-commerce pharmacy and a wholesale business for medical and pharmaceutical products under the Zur Rose and DocMorris brands in Germany, Switzerland, and rest of Europe. It offers consumer health, beauty, and personal care products. The company also provides medicines management services. It operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals. The company was formerly known as Zur Rose AG and changed its name to Zur Rose Group AG in May 2015. Zur Rose Group AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.76 out of 5 stars

Medical Sector

1274th out of 2,105 stocks

Pharmaceutical Retailers Industry

7th out of 10 stocks

Analyst Opinion: 0.0Community Rank: 3.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Zur Rose Group (OTCMKTS:ZRSEF) Frequently Asked Questions

Is Zur Rose Group a buy right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zur Rose Group in the last twelve months. There are currently 1 sell rating, 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Zur Rose Group stock.
View analyst ratings for Zur Rose Group
or view top-rated stocks.

What stocks does MarketBeat like better than Zur Rose Group?

Wall Street analysts have given Zur Rose Group a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Zur Rose Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Zur Rose Group's key executives?

Zur Rose Group's management team includes the following people:
  • Mr. Walter Oberhänsli, CEO & Exec. Director (Age 63, Pay $1.22M)
  • Mr. Marcel Ziwica, Chief Financial Officer (Age 46)
  • Mr. Bernd Gschaider, Chief Operations Officer (Age 55)
  • Christoph Herrmann, Head of Investor Relations
  • Lisa Luthi, Head of Corp. Communications
  • Mr. Walter Hess, Head of Germany (Age 56)
  • Ms. Betül Susamis Unaran, Chief Strategy & Digital Officer (Age 45)
  • Mr. David Maso, Head of Europe (Age 50)
  • Mr. Emanuel Lorini, Head of Switzerland (Age 44)

Who are some of Zur Rose Group's key competitors?

What is Zur Rose Group's stock symbol?

Zur Rose Group trades on the OTCMKTS under the ticker symbol "ZRSEF."

How do I buy shares of Zur Rose Group?

Shares of ZRSEF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Zur Rose Group's stock price today?

One share of ZRSEF stock can currently be purchased for approximately $362.00.

How many employees does Zur Rose Group have?

Zur Rose Group employs 1,960 workers across the globe.

What is Zur Rose Group's official website?

The official website for Zur Rose Group is www.zurrosegroup.com.

How can I contact Zur Rose Group?

The company can be reached via phone at 41 52 724 00 20.

This page was last updated on 6/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.